Last updated date
ABOUT THIS STUDY
This study is designed to assess the safety of Mylotarg therapy in routine practice.
Tucson, Arizona, 85404, United States
Acute Myeloid Leukemia
Females and Males
- Treated by Mylotarg
- Provide ICF
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Acute Myeloid LeukemiaCPX-351+GO in Subjects 55 Years Old, or Older, With AML
- New York, New York
Acute Myeloid LeukemiaCombination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
- München, Bayern
- Essen, NRW
- Frankfurt am Main,
Acute Myeloid LeukemiaStudy of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
- Ann Arbor, Michigan
- Omaha, Nebraska
- Chicago, Illinois
- Indianapolis, Indiana
Acute Myeloid LeukemiaAvelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
- Hershey, Pennsylvania